DD150461A5 - Verfahren zur herstellung von 2-aminoalkyl-5-pyridinolen - Google Patents

Verfahren zur herstellung von 2-aminoalkyl-5-pyridinolen Download PDF

Info

Publication number
DD150461A5
DD150461A5 DD80220844A DD22084480A DD150461A5 DD 150461 A5 DD150461 A5 DD 150461A5 DD 80220844 A DD80220844 A DD 80220844A DD 22084480 A DD22084480 A DD 22084480A DD 150461 A5 DD150461 A5 DD 150461A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
hydrogen
formula
mixture
acid addition
Prior art date
Application number
DD80220844A
Other languages
German (de)
English (en)
Inventor
Renat H Mizzoni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD150461A5 publication Critical patent/DD150461A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Paper (AREA)
  • Building Environments (AREA)
DD80220844A 1979-05-03 1980-05-02 Verfahren zur herstellung von 2-aminoalkyl-5-pyridinolen DD150461A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3566879A 1979-05-03 1979-05-03

Publications (1)

Publication Number Publication Date
DD150461A5 true DD150461A5 (de) 1981-09-02

Family

ID=21884070

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80220844A DD150461A5 (de) 1979-05-03 1980-05-02 Verfahren zur herstellung von 2-aminoalkyl-5-pyridinolen

Country Status (19)

Country Link
EP (1) EP0019739B1 (hu)
JP (1) JPS55149260A (hu)
AT (1) ATE8501T1 (hu)
DD (1) DD150461A5 (hu)
DE (1) DE3068577D1 (hu)
DK (1) DK157540C (hu)
ES (1) ES491055A0 (hu)
FI (1) FI70212C (hu)
GB (1) GB2050380B (hu)
GR (1) GR68206B (hu)
HU (1) HU181115B (hu)
IE (1) IE49712B1 (hu)
IL (1) IL59978A (hu)
MA (1) MA18964A1 (hu)
NO (1) NO154130C (hu)
OA (1) OA06528A (hu)
PL (1) PL223984A1 (hu)
PT (1) PT71176A (hu)
ZW (1) ZW9680A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746670A (en) * 1986-04-11 1988-05-24 Ciba-Geigy Corporation Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants
JP4732662B2 (ja) * 2000-04-06 2011-07-27 セイコーインスツル株式会社 電子時計の電池保持構造

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
OA06528A (fr) 1981-07-31
ES8104229A1 (es) 1981-04-01
NO154130C (no) 1986-07-23
FI70212C (fi) 1986-09-15
HU181115B (en) 1983-06-28
GR68206B (hu) 1981-11-10
FI70212B (fi) 1986-02-28
GB2050380A (en) 1981-01-07
PT71176A (en) 1980-05-01
IE800899L (en) 1980-11-03
FI801411A (fi) 1980-11-04
DK193180A (da) 1980-11-04
IL59978A0 (en) 1980-07-31
EP0019739A1 (de) 1980-12-10
NO154130B (no) 1986-04-14
JPS55149260A (en) 1980-11-20
ES491055A0 (es) 1981-04-01
ATE8501T1 (de) 1984-08-15
PL223984A1 (hu) 1981-02-13
ZW9680A1 (en) 1980-11-26
DE3068577D1 (en) 1984-08-23
IE49712B1 (en) 1985-11-27
NO801267L (no) 1980-11-04
JPS6365662B2 (hu) 1988-12-16
MA18964A1 (fr) 1980-12-31
IL59978A (en) 1984-03-30
DK157540C (da) 1990-06-11
GB2050380B (en) 1983-07-20
EP0019739B1 (de) 1984-07-18
DK157540B (da) 1990-01-22

Similar Documents

Publication Publication Date Title
EP0163965B1 (de) Pyridazinone, ihre Herstellung und Verwendung, Pyridazinone enthaltende Arzeimittel
DD201887A5 (de) Verfahren zur herstellung von 1-carboxyalkanoylindolin-2-carbonsaeuren
DE2856753A1 (de) N-substituierte omega -aminoalkanoyl- omega -aminoalkansaeuren, ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE2455353C3 (de) Substituierte a -Aminooxvcarbonsäurehydrazidderivate und ihre Säureadditionssalze sowie ihre Verwendung vnd Verfahren zur Herstellung derselben
DE68917772T2 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
DD149511A5 (de) Verfahren zur herstellung von 9-aminoalkylfluorenen
CH627745A5 (de) Verfahren zur herstellung von bis-quartaeren pyridinium-2-aldoxim-salzen.
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DD150461A5 (de) Verfahren zur herstellung von 2-aminoalkyl-5-pyridinolen
EP0033919B1 (de) Substituierte Phosphin- und Phosphonsäuren, Verfahren und Zwischenprodukte zu ihrer Herstellung, diese enthaltende Arzneimittel und deren therapeutische Verwendung
DE2404328A1 (de) Verfahren zur herstellung von alpha(l-aralkylaminoalkyl)-aralkoxybenzylalkoholen
EP0012801A1 (de) 2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel
EP0073997A1 (de) Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE3347657A1 (de) Neue 1,4-naphthochinonderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4285942A (en) Cyclododecanone oximes
EP0462150B1 (de) Neue aryloxy-alkylamine, deren herstellung und diese enthaltende arzneimittel
DE2609862A1 (de) Verbindungen mit antidepressiver wirkung
DE2923817B1 (de) (3-Alkylamino-2-hydroxypropoxy)-furan-2-carbonsaeureanilide und deren physiologisch vertraegliche Saeureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
EP0266711A1 (de) Neue 2,6-Diamono-3-halogenobenzyl-pyridine und Verfahren zu ihrer Herstellung sowie ihre Verwendung in Pharmazeutika
DE2552196A1 (de) Verfahren zur herstellung von neuen 7,7-diphenylhexahydro-1,4-oxazepinen
DE3220185A1 (de) 4-amino-benzylamin-derivate, verfahren zu ihrer herstellung, sowie ihre verwendung als pharmazeutica
US3884954A (en) 12-Cyano-5,6,7,12-tetrahydrodibenzo{8 a,d{9 cyclooctenes
DE2031360A1 (de) Neue cyclische Verbindungen und Ver fahren zu ihrer Herstellung
AT345291B (de) Verfahren zur herstellung von neuen cyclisch substituierten derivaten des 1-amino-2-propanols und deren salzen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee